Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOnward Opps Regulatory News (ONWD)

Share Price Information for Onward Opps (ONWD)

Share Price is delayed by 15 minutes
Get Live Data
123.50    0.00 (0.00%)
Bid:
122.00
Ask:
125.00
Spread: 3.00 (2.459%)
Market Cap: £41.18m
ONWD Live PriceLast checked at - London Stock Exchange

Intraday Onward Opps Share Chart

Net Asset Value(s)

2 Sep 2025 07:00

RNS Number : 5238X
Onward Opportunities Limited
02 September 2025
 

 

Onward Opportunities Limited

("Onward Opportunities" or the "Company")

 

 

Net Asset Value

 

Onward Opportunities announces that as at 31 August 2025, the unaudited net asset value ("NAV") per ordinary share was 129.26 pence, an increase of 2.39% versus the previous month end.

 

The above NAV calculation is based on the Company's issued share capital as at 31 August 2025 of 27,251,521 ordinary shares of no par value.

 

For further information, please contact:

 

 

Onward Opportunities Limited

Andrew Henton, Chairman

 

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Investment Director

 

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

 

 

NSM Funds Limited (Company Secretary)

 

Tel: +44 (0) 1481 743030

onwardopportunities@nsm.group

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Ben Jeynes / Hamish Waller

 

Tel: +44 (0)20 7200 0500

Dowgate Capital Limited (Joint Broker)

Nicholas Chambers / Russell Cook

 

Tel: +44 (0)20 3903 7715

 

 

About Onward Opportunities

Onward Opportunities is an investment company focussed on the UK small cap market, led by an Investment Committee and Lead Manager with over 160 years' combined experience.

Onward has a clear investment strategy, to capitalise on the significant valuation anomalies arising from a lack of investor information on UK small and micro-cap stocks. Through its analysis, experience and deep understanding of the UK Small Cap market, Onward Opportunities is able to identify these anomalies, enabling investment in opportunities with superior potential upside.

The investment philosophy is to focus on companies with competitive advantage, strong management track record, balance sheet asset backing, attractive cash flow potential and visibility of earnings. Investee companies will also have scope for material potential valuation upside that can be delivered from catalysing strategic, operational or management initiatives. Onward Opportunities helps its portfolio companies realise this potential through active engagement.

Since IPO in March 2023, the investment strategy and philosophy have proven successful, consistently outperforming the AIM All Share Index. Onward Opportunities' investment objective is to deliver a return on investments of at least 2.0x invested capital over a three-to-five-year hold period, aggregating into a total annualised return of at least 15% per annum.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVUPUQUBUPAGBG
12
Date   Source Headline
13th Nov 202510:32 amRNSHolding(s) in Company
6th Nov 20257:00 amRNSIssue of Equity
4th Nov 20257:00 amRNSNet Asset Value(s)
16th Oct 20254:54 pmRNSHolding(s) in Company
14th Oct 20251:09 pmRNSPublication of Q3 2025 Factsheet
10th Oct 20257:00 amRNSAdditional Subscription and Total Voting Rights
7th Oct 20257:00 amRNSIssue of Equity
1st Oct 20253:33 pmRNSNet Asset Value(s)
8th Sep 20257:00 amRNSHalf-year Report
2nd Sep 20257:00 amRNSNet Asset Value(s)
4th Aug 202512:57 pmRNSNet Asset Value(s)
25th Jul 202510:05 amRNSHolding(s) in Company
24th Jul 20257:00 amRNSHalf-Year Update
21st Jul 20257:00 amRNSAdditional Subscription and Total Voting Rights
16th Jul 20257:00 amRNSIssue of Equity
7th Jul 20257:00 amRNSPublication of Q2 2025 Factsheet
2nd Jul 20253:47 pmRNSNet Asset Value(s)
16th Jun 202512:49 pmRNSResult of AGM
3rd Jun 20257:00 amRNSNet Asset Value
2nd Jun 20257:00 amRNS-RInaugural Investor Day
29th May 20257:00 amRNSNotice of AGM
7th May 20251:29 pmRNSDirector Dealing
6th May 20257:00 amRNSChange of Service Providers and Registered Office
2nd May 20259:26 amRNSNet Asset Value(s)
16th Apr 20255:33 pmRNSHolding(s) in Company
2nd Apr 20252:50 pmRNSNet Asset Value(s)
20th Mar 20257:00 amRNSAdditional Subscription and Total Voting Rights
18th Mar 20257:00 amRNSAnnual Results
14th Mar 20257:00 amRNSIssue of Equity and Total Voting Rights
11th Mar 20255:02 pmRNSHolding(s) in Company
4th Mar 20254:59 pmRNSNet Asset Value(s)
4th Feb 20255:10 pmRNSHolding(s) in Company
4th Feb 20251:46 pmRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSAmalgamation of Administrator
16th Jan 20257:00 amRNSPublication of Q4 2024 Factsheet
14th Jan 20257:00 amRNSFull-Year Update
2nd Jan 20255:50 pmRNSNet Asset Value(s)
6th Dec 20247:00 amRNSAdditional Subscription and Total Voting Rights
4th Dec 20247:00 amRNSIssue of Equity
2nd Dec 20245:38 pmRNSNet Asset Value(s)
1st Nov 20244:42 pmRNSNet Asset Value(s)
30th Oct 20244:40 pmRNSHolding(s) in Company
24th Oct 202412:00 pmRNSIssue of Equity
11th Oct 20247:00 amRNSPublication of Q3 2024 Factsheet
3rd Oct 20243:44 pmRNSHolding(s) in Company
2nd Oct 20244:34 pmRNSNet Asset Value(s)
26th Sep 20243:27 pmRNSAdditional Subscription and Total Voting Rights
26th Sep 20247:00 amRNSIssue of Equity
6th Sep 20247:00 amRNSHalf-year Report
3rd Sep 20244:21 pmRNSNet Asset Value
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.